2013 Research Development Awards Request for Applications (RFA ...

8. Letters documenting feasibility: Demonstrations of feasibility will vary based on study focus,design, and specific intervention; examples include letters from (1) the pharmaceutical companyassuring access to the investigational agent; (2) a clinic manager committing to facilitaterecruitment of a specific population; or (3) the department/division confirming collaboration.9. Attach Animal or Human Subjects approvals if needed. All new cancer-related research involvinghuman subjects, needs approval by the Human Research Protection Office (HRPO), and mustfirst be reviewed and approved by the Siteman Cancer Center Protocol Review and MonitoringCommittee (PRMC). Funds will not be released prior to PRMC and HRPO approval. Pleaseinclude a page explaining your project’s human participation (from HRPO application), or theanticipated date you will be submitting to the PRMC/HRPO, and when approval is expected.10. Letters of Support: Include a letter of support from the Core director of the core(s) you will beusing in your research. If the project requires a sponsor, consultant or collaborator, this individualshould write a letter of support for the application, including an explanation of how any overlap ineffort will be reconciled if the project is funded. Junior faculty applicants (instructor or assistantprofessor) are required to submit a letter of support from their Department or Division chair.Expenditures Allowed Salary support for the applicant as needed Research supplies and animal maintenance (including animal per diem charges) Per diem charges for patients if part of a clinical study not reimbursable by standard paymentterms Technical assistance Publication costs, including reprints, study instruments, surveys, etc. Costs of computer time Special fees (pathology, photography, etc.)Expenditures NOT Allowed Secretarial/administrative personnel salary support Office equipment and supplies Computer/equipment maintenance fees Tuition Indirect institutional costs TravelIf you have questions, please contact Paige Isom, isomp@wudosis.wustl.edu , 314-454-8981.F. Terms of the AwardThese funds are for one year. It is expected that the grantee will completely utilize the full amountof funding during the one-year term of the award. No-cost extensions of one year may be grantedwith the approval of the RDA Review Committee. Requests must be made 30 days prior to theend of the funding period. All unspent funds at the end of the grant period (unless you haverequested and been granted a no-cost extension) will be returned.HRPO & PRMC approvals are not required at the time of submission. However, all awards musthave appropriate institutional regulatory approvals (SCC Protocol Review and MonitoringCommittee, Human Research Protection Office, Animal Studies, Radiation Safety) before fundswill be transferred.A progress report will be required to be submitted no later than 60 days following the end of thefunding period and for the following 3-5 years to capture any subsequent grants or publications.3